2010
DOI: 10.7150/ijms.7.358
|View full text |Cite
|
Sign up to set email alerts
|

Pravastatin Provides Antioxidant Activity and Protection Of Erythrocytes Loaded Primaquine

Abstract: Loading erythrocytes with Primaquine (PQ) is advantageous. However, PQ produces damage to erythrocytes through free radicals production. Statins have antioxidant action and are involved in protective effect against situation of oxidative stress. Thus the protective effect of pravastatin (PS) against PQ induced oxidative damage to human erythrocytes was investigated in the current studies upon loading to erythrocytes.The erythrocytes were classified into; control erythrocytes, erythrocytes incubated with either… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
11
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 30 publications
2
11
0
Order By: Relevance
“…This result is may be an evident to the quite effect of loading process on erythrocytes and/or protective effect of pravastatin as investigated in previous study stated that the pravastatin protect erythrocytes against oxidative damage induced by drugs 35.…”
Section: Resultsmentioning
confidence: 51%
“…This result is may be an evident to the quite effect of loading process on erythrocytes and/or protective effect of pravastatin as investigated in previous study stated that the pravastatin protect erythrocytes against oxidative damage induced by drugs 35.…”
Section: Resultsmentioning
confidence: 51%
“…According to the preferred therapeutic approach, erythrocytes are used either as carriers for the sustained release of the drugs or to target the drugs to specific organs (Hamidi et al, 2007b). The maintenance of the normal oxidant/antioxidant balance in erythrocytes during drug encapsulation may help to produce loaded cells with characteristics similar to those of normal erythrocytes (Alanazi, 2010). In this case, such drug-loaded cells can be used as slow-release carriers for the entrapped drugs (Hamidi et al, 2007b).…”
Section: Introductionmentioning
confidence: 99%
“…Sheep blood derived specimens conducted in this experiment were approved by National Laboratory Animal Center-Animal Care and Use Committee, Mahidol University (approval number RA2011.03). Erythrocyte isolation was performed as described in Alanazi, 2010, [15] with slight modifications. Alsevers blood was centrifuged for 5 min at 1,500 rpm at 4°C.…”
Section: Methodsmentioning
confidence: 99%
“…Ten fields of erythrocytic smear per group of the experiment were randomly examined and captured at 3,000x magnification. Each type of dysmorphic erythrocyte described in several reports [15, 17–20] was identified and counted as percentage/field.…”
Section: Methodsmentioning
confidence: 99%